• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background

    Diabetes Pen Companies

    ID: MRFR/MED/0146-HCR
    105 Pages
    Rahul Gotadki
    October 2025

    The market for diabetes pens involves several multinational pharmaceutical and medical device companies that manufacture insulin pens for diabetes management. These companies operate globally, including in the Americas.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Top Industry Leaders in the Diabetes Pen Market

    Americas Diabetes Pen Key Companies

     

    Latest Americas Diabetes Pen Companies Update


    Novo Nordisk price reduction: In March 2023, Novo Nordisk announced a 75% price reduction for vials and pens of NovoLog and other insulin brands in the United States. This move is expected to increase the adoption of insulin pens, particularly among cost-conscious consumers.


    Cequr's new insulin pen: In June 2022, Cequr launched its Insulin Pen 2.0TM, which features advanced features like automated insulin delivery, real-time glucose monitoring, and personalized dosing recommendations. This pen is expected to be a game-changer in the market for smart insulin pens.


    List of Americas Diabetes Pen Key Companies in the Market



    • Becton, Dickinson And Company

    • Novo Nordisk A/S

    • Ypsomed Holding Ag

    • Owen Mumford, Ltd.

    • Sanofi

    • Eli Lilly

    • Merck Animal Health